Your browser doesn't support javascript.
loading
Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial.
Robinson, Delbert G; Schooler, Nina R; Marcy, Patricia; Gibbons, Robert D; Hendricks Brown, C; John, Majnu; Mueser, Kim T; Penn, David L; Rosenheck, Robert A; Addington, Jean; Brunette, Mary F; Correll, Christoph U; Estroff, Sue E; Mayer-Kalos, Piper S; Gottlieb, Jennifer D; Glynn, Shirley M; Lynde, David W; Gingerich, Susan; Pipes, Ronny; Miller, Alexander L; Severe, Joanne B; Kane, John M.
Afiliação
  • Robinson DG; Departments of Psychiatry and of Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Schooler NR; The Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.
  • Marcy P; The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, NY, USA.
  • Gibbons RD; Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY, USA.
  • Hendricks Brown C; Vanguard Research Group, Glen Oaks, NY, USA.
  • John M; Center for Health Statistics, University of Chicago, Chicago, IL, USA.
  • Mueser KT; Departments of Psychiatry and Behavioral Sciences, Preventive Medicine and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Penn DL; The Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.
  • Rosenheck RA; Department of Mathematics, Hofstra University, Hempstead, NY, USA.
  • Addington J; Center for Psychiatric Rehabilitation, Boston University, Boston, MA, USA.
  • Brunette MF; Department of Psychology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
  • Correll CU; School of Behavioural and Health Sciences, Australian Catholic University, Melbourne, Victoria, Australia.
  • Estroff SE; Department of Psychiatry, Yale Medical School, New Haven, CT,USA.
  • Mayer-Kalos PS; Department of Psychiatry, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
  • Gottlieb JD; Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
  • Glynn SM; Departments of Psychiatry and of Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Lynde DW; The Feinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.
  • Gingerich S; The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, NY, USA.
  • Pipes R; Department of Child and Adolescent Psychiatry, Charite Universitatsmedizin, Berlin, Germany.
  • Miller AL; Department of Social Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
  • Severe JB; Department of Psychiatry & Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Kane JM; Division of Population Behavioral Health Innovation and Harvard Medical School, Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA, USA.
Schizophr Bull ; 48(5): 1021-1031, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35689478
To examine long-term effects of early intervention services (EIS) for first-episode psychosis, we compared Heinrichs-Carpenter Quality of Life (QLS) and Positive and Negative Syndrome Scale (PANSS) scores and inpatient hospitalization days over 5 years with data from the site-randomized RAISE-ETP trial that compared the EIS NAVIGATE (17 sites; 223 participants) and community care (CC) (17 sites; 181 participants). Inclusion criteria were: age 15-40 years; DSM-IV diagnoses of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, or psychotic disorder not otherwise specified; first psychotic episode; antipsychotic medication taken for ≤6 months. NAVIGATE-randomized participants could receive NAVIGATE from their study entry date until NAVIGATE ended when the last-enrolled NAVIGATE participant completed 2 years of treatment. Assessments occurred every 6 months. 61% of participants had assessments conducted ≥2 years; 31% at 5 years. Median follow-up length was CC 30 months and NAVIGATE 38 months. Primary analyses assumed data were not-missing-at-random (NMAR); sensitivity analyses assumed data were missing-at-random (MAR). MAR analyses found no significant treatment-by-time interactions for QLS or PANSS. NMAR analyses revealed that NAVIGATE was associated with a 13.14 (95%CI:6.92,19.37) unit QLS and 7.73 (95%CI:2.98,12.47) unit PANSS better improvement and 2.53 (95%CI:0.59,4.47) fewer inpatient days than CC (all comparisons significant). QLS and PANSS effect sizes were 0.856 and 0.70. NAVIGATE opportunity length (mean 33.8 (SD = 5.1) months) was not associated (P = .72) with QLS outcome; duration of untreated psychosis did not moderate (P = .32) differential QLS outcome. While conclusions are limited by the low rate of five-year follow-up, the data support long-term benefit of NAVIGATE compared to community care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article